161 related articles for article (PubMed ID: 8012985)
1. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues.
Xu XC; Ro JY; Lee JS; Shin DM; Hong WK; Lotan R
Cancer Res; 1994 Jul; 54(13):3580-7. PubMed ID: 8012985
[TBL] [Abstract][Full Text] [Related]
2. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
Lotan R
Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
[TBL] [Abstract][Full Text] [Related]
3. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.
Jiang SY; Shen SR; Shyu RY; Yu JC; Harn HJ; Yeh MY; Lee MM; Chang YC
Br J Cancer; 1999 Apr; 80(1-2):206-14. PubMed ID: 10389997
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoic acid receptors in squamous cell carcinomas and their possible implication for chemoprevention.
Issing WJ; Wustrow TP
Anticancer Res; 1996; 16(4C):2373-7. PubMed ID: 8816837
[TBL] [Abstract][Full Text] [Related]
5. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
6. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
7. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.
Xu XC; Wong WY; Goldberg L; Baer SC; Wolf JE; Ramsdell WM; Alberts DS; Lippman SM; Lotan R
Cancer Res; 2001 Jun; 61(11):4306-10. PubMed ID: 11389049
[TBL] [Abstract][Full Text] [Related]
8. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
Xu XC; Sozzi G; Lee JS; Lee JJ; Pastorino U; Pilotti S; Kurie JM; Hong WK; Lotan R
J Natl Cancer Inst; 1997 May; 89(9):624-9. PubMed ID: 9150186
[TBL] [Abstract][Full Text] [Related]
9. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.
Zou CP; Clifford JL; Xu XC; Sacks PG; Chambon P; Hong WK; Lotan R
Cancer Res; 1994 Oct; 54(20):5479-87. PubMed ID: 7522960
[TBL] [Abstract][Full Text] [Related]
10. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.
Xu XC; Sneige N; Liu X; Nandagiri R; Lee JJ; Lukmanji F; Hortobagyi G; Lippman SM; Dhingra K; Lotan R
Cancer Res; 1997 Nov; 57(22):4992-6. PubMed ID: 9371489
[TBL] [Abstract][Full Text] [Related]
11. Expression of retinoid receptors in sebaceous cell carcinoma.
Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
[TBL] [Abstract][Full Text] [Related]
12. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.
Widschwendter M; Berger J; Daxenbichler G; Müller-Holzner E; Widschwendter A; Mayr A; Marth C; Zeimet AG
Cancer Res; 1997 Oct; 57(19):4158-61. PubMed ID: 9331065
[TBL] [Abstract][Full Text] [Related]
13. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.
Lotan R; Xu XC; Lippman SM; Ro JY; Lee JS; Lee JJ; Hong WK
N Engl J Med; 1995 May; 332(21):1405-10. PubMed ID: 7723796
[TBL] [Abstract][Full Text] [Related]
14. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors.
Darwiche N; Celli G; Tennenbaum T; Glick AB; Yuspa SH; De Luca LM
Cancer Res; 1995 Jul; 55(13):2774-82. PubMed ID: 7540949
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis.
Xu XC; Lee JS; Lippman SM; Ro JY; Hong WK; Lotan R
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):871-6. PubMed ID: 8634660
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
[TBL] [Abstract][Full Text] [Related]
17. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
19. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention].
Issing WJ
Laryngorhinootologie; 2001 Sep; 80(9):530-4. PubMed ID: 11555786
[TBL] [Abstract][Full Text] [Related]
20. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
